Global Pharmaceuticals & Biotech Big Green Snowflakes

Pathfinder Cell Therapy

Market Cap: US$667.0

A development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage.

RxElite

Market Cap: US$116.0

Engages in the development, manufacture, and marketing of generic prescription drug products in specialty generic markets.

Ember Therapeutics

Market Cap: US$43.0

Operates as a clinical stage biopharmaceutical company.

House of Jane

Market Cap: US$44.1m

Provides lifestyle therapy products.

INDVR Brands

Market Cap: €314.1k

Provides personnel and management resources, and infrastructure and equipment for use in production, cultivation, and dispensary operations of licensed cannabis businesses in the United States.

PsyBio Therapeutics

Market Cap: US$132.0

A biotechnology company, engages in the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States.

Arno Therapeutics

Market Cap: US$49.0

A biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases.

Spencer Pharmaceutical

Market Cap: US$271.0

Develops drug platform technologies for the treatment of neurological deceases.

Response Genetics

Market Cap: US$38.0

A life sciences company, researches, develops, markets, and sells pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and internationally.

EVIO

Market Cap: US$19.2k

Provides analytical testing and consulting services for cannabis and hemp industry.

TetraLogic Pharmaceuticals

Market Cap: US$4.9k

A clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases.

PhaseRx

Market Cap: US$1.2k

A biopharmaceutical company, engages in developing a portfolio of products for the treatment of inherited enzyme deficiencies in the liver using intracellular enzyme replacement therapy.

Poniard Pharmaceuticals

Market Cap: US$149.0

A biopharmaceutical company, focuses on the development and commercialization of cancer therapeutics.

Suvanza Pharma

Market Cap: US$2.2k

Operates as an early-stage biotechnology corporation and engages in the development of the skin drug delivery system, RapiDerm for dermatologic diseases.

BG Medicine

Market Cap: US$1.1k

Engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States.

Arrayit

Market Cap: US$2.3k

A life sciences technology company, develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation, biological function, and diagnostics worldwide.

GeNeuro

Market Cap: €882.0k

A clinical-stage biopharmaceutical company, develops drugs for the treatment of neurodegenerative and autoimmune diseases.

Fresh2 Group

Market Cap: US$222.0

A biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People’s Republic of China.

ObsEva

Market Cap: US$58.6k

A biopharmaceutical company, focuses on the development of novel therapies to improve women’s reproductive health.

Todos Medical

Market Cap: US$3.3k

A vitro diagnostics company, develops and commercializes blood tests for the detection of cancer and Alzheimer disease in the United States.

Inmolecule Nanotech

Market Cap: €28.7m

A biotech company, develops active ingredient nano particles for various applications in the home and personal care, agriculture, aquaculture, and pharmaceutical industries.

SQZ Biotechnologies

Market Cap: US$825.8k

A clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions.

Cardiac Biotech Solutions

Market Cap: US$6.2m

Through its subsidiaries, provides various products and services in the ambulatory non-invasive cardiac monitoring space in the United States and internationally.

Nidhogg Resources Holding

Market Cap: SEK 16.5m

Operates in the natural resources sector primarily in Sweden.

VG Life Sciences

Market Cap: US$2.1m

A biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation.

MPX International

Market Cap: US$14.4k

Operates as a cannabis company in Canada and internationally.

Nouveau Life Pharmaceuticals

Market Cap: US$6.7k

A development stage company, engages in the development of nutraceuticals products.

Eagle Pharmaceuticals

Market Cap: US$40.2m

A pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States.

CTT Pharmaceutical Holdings

Market Cap: US$2.8m

Engages in the development of oral drug delivery systems for pain management and treatment.

Synovics Pharmaceuticals

Market Cap: US$3.6k

Through its subsidiaries, engages in the development, manufacture, and commercialization of generic over-the-counter (OTC) pharmaceutical products and generic prescription drug products primarily in the United States.

Eden Empire

Market Cap: US$137.0

Invests in and operates in the cannabis sector.

Korver

Market Cap: US$3.6k

Engages in the design and manufacture of integrated machine controls that are sold to manufacturers of plastic parts for the automotive, household products, and electronics industries worldwide.

Aida Pharmaceuticals

Market Cap: US$5.4k

Engages in the formulation, clinical testing, registration, manufacture, sales, and marketing of pharmaceutical and genetic products in mainland China.

White Label Liquid

Market Cap: US$6.4k

Provides manufacturing service for custom-blended products containing hemp-derived CBD oil.

J. Molner

Market Cap: €44.8m

A pharmaceutical company, provides research and development services for pharmaceutical companies in the United States, Canada, and Europe.

Halo Collective

Market Cap: US$150.0

Engages in the cultivation, manufacture, transportation, and distribution of cannabis and cannabis extracts in Canada and the United States.